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ABSTRACT
Background Patients with functional motor disorder
(FMD) including weakness and paralysis are commonly
referred to physiotherapists. There is growing evidence
that physiotherapy is an effective treatment, but the
existing literature has limited explanations of what
physiotherapy should consist of and there are insufﬁcient
data to produce evidence-based guidelines. We aim to
address this issue by presenting recommendations for
physiotherapy treatment.
Methods A meeting was held between
physiotherapists, neurologists and neuropsychiatrists, all
with extensive experience in treating FMD. A set of
consensus recommendations were produced based on
existing evidence and experience.
Results We recommend that physiotherapy treatment is
based on a biopsychosocial aetiological framework.
Treatment should address illness beliefs, self-directed
attention and abnormal habitual movement patterns
through a process of education, movement retraining
and self-management strategies within a positive and
non-judgemental context. We provide speciﬁc examples
of these strategies for different symptoms.
Conclusions Physiotherapy has a key role in the
multidisciplinary management of patients with FMD.
There appear to be speciﬁc physiotherapy techniques
which are useful in FMD and which are amenable to
and require prospective evaluation. The processes
involved in referral, treatment and discharge from
physiotherapy should be considered carefully as a part of
a treatment package.
INTRODUCTION
Many regard physiotherapy for functional motor
disorders (FMD) as a useful part of treatment and
there is increasing evidence for its use including a
randomised controlled trial.1–3 There is, however,
very little description, even in these studies, of
what physiotherapy should actually consist of. A
common view of physiotherapy for FMD is that
when it helps, it does so only by providing a ‘face
saving way-out’ for patients (another way of saying
that the precise elements of treatment are unim-
portant as recovery is entirely under the control of
the patient). On the contrary, evidence is emerging
that the composition of physiotherapy does matter
and that targeted physiotherapy based on an under-
pinning scientiﬁc rationale and embedded in trans-
parent communication can address mechanisms
that produce and maintain FMD. We therefore met
as a group of geographically diverse and multidis-
ciplinary health professionals to create recommen-
dations for the content of physiotherapy for FMD
to act as a guide for others and to form the basis of
further treatment studies.
We use the term FMD to denote symptoms such
as weakness, paralysis, tremor and dystonia that are
not caused by a standard neurological disease.
FMDs are among the most common reasons for
people to seek neurological advice.4 They are asso-
ciated with high levels of disability and distress,
prognosis is considered poor and the ﬁnancial
burden is high.5–7
In a recent survey of UK neurophysiotherapists,8
it was found that most (77%) saw patients with
FMD and had good levels of interest in treating
patients with FMD. A lack of support from non-
physiotherapy colleagues and inadequate service
structures were commonly identiﬁed barriers to
treatment. In addition, they rated their knowledge
as low compared to other commonly seen condi-
tions. This is not surprising, given the lack of evi-
dence and descriptions of treatment techniques. In a
recent systematic review of physiotherapy for
FMD,3 only 29 studies were identiﬁed with a com-
bined total of 373 patients (only seven studies had
more than 10 participants). Despite their limita-
tions, these studies show promising results for
physiotherapy (and physical rehabilitation), with
improvement in 60–70% of patients. In addition, a
recently published randomised trial of 60 patients
showed highly encouraging results from a 3-week
inpatient physical rehabilitation intervention in
patients with functional gait disorder (7 point
improvement on a 15 point scale).1 However, the
literature contains little practical advice about how
best to carry out physiotherapy in an individual with
FMD. There are no existing published recommen-
dations. We attempt to address this issue by provid-
ing recommendations for physiotherapy practice.
We introduce a pathophysiological model for
FMDs, on which we base our treatment strategies
and provide practical suggestions for the patient
journey from referral to treatment and discharge.
DEVELOPMENT OF RECOMMENDATIONS
In 2013, an occupational therapist, physiothera-
pists, neurologists and neuropsychiatrists, all with
extensive experience in treating patients with
FMD, met in Edinburgh, UK to produce a set of
recommendations for physiotherapy treatment.
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This is explicitly not a guideline because of the lack of evidence
available. Instead, the recommendations seek to combine the
existing evidence in the literature1 3 with experience from
health professionals into a document that can form the basis of
further studies and can be developed further as new evidence
emerges.
This published document is shortened from a longer version
available as an online supplementary ﬁle, which contains more
examples of ways to discuss certain scenarios and also case
examples.
SYMPTOM MODEL AND RATIONALE FOR PHYSIOTHERAPY
Our aetiological framework is a biopsychosocial framework in
which heterogeneous mixtures of predisposing, precipitating
and perpetuating factors need to be considered and formulated
with the acceptance that relevant factors differ between different
patients (table 1).
More speciﬁcally, for FMD we base some of our recommenda-
tions on a model for the mechanism of symptoms which may be
more homogeneous between patients. In this model, FMD is
conceived as an involuntary but learnt habitual movement
pattern driven by abnormal self-directed attention. We emphasise
that this is commonly triggered by physical or psychophysiological
events such as injury, illness, pain and dissociation with panic and
is mediated by illness beliefs and expectation.9–11 Life events, emo-
tional disorder and personality traits are relevant in understanding
and treating some patients with FMD, especially in cases where a
clear link exists between mood/anxiety and symptom exacerbation.
However, our recommendations, in keeping with revised criteria
in the Diagnostic and Statistical Manual of Mental Disorders ﬁfth
edition (in DSM-5),12 move away from an assumption that ‘recent
stress’ and a purely psychological model are essential to under-
stand and treat patients with FMD.
PHYSIOTHERAPY WITHIN A MULTIDISCIPLINARY
APPROACH TO FMD
Physiotherapy is one of many interventions that may help FMD.
Others may include simple education, psychological treatment,
occupational therapy, speech and language therapy, hypnosis,
medication and vocational rehabilitation. We recommend,
however, for patients with physical disability that physiotherapy
informed by awareness of the complexities of FMD should take
a primary role in treatment in many patients. We also suggest
that when psychological treatment is indicated, in some cases it
may be more effectively delivered after or alongside successful
physiotherapy:
We propose that physiotherapy has an important role in normal-
ising illness beliefs, reducing abnormal self-directed attention and
breaking down learnt patterns of abnormal movement through.
1. Education
2. Demonstration that normal movement can occur
3. Retraining movement with diverted attention
4. Changing maladaptive behaviours related to symptoms.
DIAGNOSIS, PHYSICIAN EXPLANATION AND REFERRAL TO
PHYSIOTHERAPY
Recommendations for assessment and correct diagnosis of FMD
are available elsewhere.14 15 There is a consensus among
health professionals regarding the importance of a clear phys-
ician explanation to the patient and their carers regarding the
diagnosis16 17 (detailed further below). The critical outcomes of
the explanation which appear to facilitate physiotherapy are:
1. An understanding by the patient that their treating health
professionals accept that they have a genuine problem (ie,
not ‘imagined’ or ‘made up’);
2. An understanding by the patient that they have a problem
which has the potential for reversibility (ie, a problem with
function of the nervous system, not damage to the nervous
system) and thus is amenable to physiotherapy.
A physician referral to physiotherapy for FMD should ideally
contain a description of what the patient has been told and
should be shared with the patient. Awareness of other relevant
symptoms that may be present such as pain, fatigue, memory and
concentration problems, anxiety and depression is important.
Not all patients with FMD are suitable for physiotherapy. We
recommend that the following criteria should usually be met:
1. Patients should have received an unambiguous diagnosis of
FMD by a physician, preferably using the recommendations
above.
2. The patient should have some conﬁdence in or openness to
the diagnosis of FMD. Physiotherapy is unlikely to be
helpful to someone who believes the diagnosis is wrong.
Table 1 A range of potential mechanisms and aetiological factors in patients with functional motor disorders
Factors Biological Psychological Social
Factors acting at all
stages
▸ ‘Organic’ disease
▸ History of previous functional symptoms
▸ Emotional disorder
▸ Personality disorder
▸ Socio-economic/deprivation
▸ Life events and difficulties
Predisposing
vulnerabilities
▸ Genetic factors affecting personality
▸ Biological vulnerabilities in the nervous system
▸ Perception of childhood experience as
adverse
▸ Personality traits
▸ Poor attachment/coping style
▸ Childhood neglect/abuse
▸ Poor family functioning
▸ Symptom modelling of others
Precipitating
mechanisms
▸ Abnormal physiological event or state (eg,
drug side effect hyperventilation, sleep
deprivation, sleep paralysis)
▸ Physical injury/pain
▸ Perception of life event as negative,
unexpected
▸ Acute dissociative episode/panic
attack.
Perpetuating factors ▸ Plasticity in CNS motor and sensory (including
pain) pathways leading to habitual abnormal
movement
▸ Deconditioning
▸ Neuroendocrine and immunological
abnormalities
similar to those seen in depression and anxiety
▸ Illness beliefs (patient and family)
▸ Perception of symptoms as being
irreversible
▸ Not feeling believed
▸ Perception that movement causes
damage
▸ Avoidance of symptom provocation
▸ Fear of falling
▸ Social benefits of being ill
▸ Availability of legal compensation
▸ Ongoing medical investigations and
uncertainty
▸ Excessive reliance on sources of information or
group affiliations which reinforce beliefs that
symptoms are irreversible and purely physical
in nature
Adapted from Stone and Carson.13
CNS, central nervous system.
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3. The patient desires improvement and can identify treatment
goals.
Patients who do not fulﬁl all of these criteria may still beneﬁt
from physiotherapy. For example, to help them understand the
diagnosis or for disability management where rehabilitation has
explicitly failed. Not all patients with an acute onset of FMD
will require additional speciﬁc treatment. A proportion will
experience spontaneous remission, but follow-up studies have
shown that the majority of patients remain symptomatic in the
long term.6 18 Since chronicity of symptoms is associated with
poor outcome, we would still recommend early referral of
appropriate patients to physiotherapy. The question of how
much spontaneous improvement might account for the beneﬁt
seen from physiotherapy (or indeed any other treatment) is one
that needs to be answered via randomised clinical trials.
PHYSIOTHERAPY ASSESSMENT
This is discussed in detail in the online supplementary material.
The key elements are: to gain a detailed understanding of the
range of symptoms experienced; the effect on day-to-day func-
tion; the patient’s understanding of and level of conﬁdence in
the diagnosis already given; setting goals for physiotherapy
treatment and gaining rapport. If it is clear at this stage that the
patient has very ﬁxed views about an alternative diagnosis or
has no wish to have physiotherapy, then it may not be appropri-
ate to proceed. The use of a treatment contract, as in other dis-
orders, may have beneﬁts in providing impetus for change and
assisting discharge of patients not beneﬁting from treatment.
COMPONENTS OF PHYSIOTHERAPY
Broad principles which apply to treatment of most patients with
FMD are shown in box 1.
Education
The physiotherapist, like the physician, is in an excellent pos-
ition to improve the patient’s understanding of their disorder
throughout treatment. The explanation given should build on a
thorough explanation from the referring physician.15 Useful
ingredients include:
1. Use of the term functional movement disorder/limb weak-
ness/paralysis/tremor/dystonia/myoclonus to describe the dis-
order. The rationale for this in preference to ‘psychogenic’ or
conversion disorder or other terms is explained elsewhere.19
2. Acknowledgement that such symptoms are real, and are not
imagined or ‘put on’ (ie, you believe them).
3. Acknowledgement that such symptoms are common and
that they are commonly seen by the treating physiotherapist.
4. Explanation that symptoms can get better, that the problem
is to do with nervous system functioning, not irreversible
damage to the nervous system.
5. Explanation of how FMD is diagnosed using the demonstra-
tion of positive clinical signs which demonstrate normal
movement (see below).
6. Explanation that a wide variety of factors may be involved
in triggering symptoms, including physical illness and injury,
and that psychological factors such as anxiety, depression or
trauma may also be important.
7. Introducing the role of physiotherapy in ‘retraining’ the
nervous system to help regain control over movement.
8. It may be important to discuss other terms used for FMD
and the fact that many health professionals have ambivalent
or negative attitudes to FMD.
This information should be backed up with written or online
information (eg, http://www.neurosymptoms.org). In patients in
whom doubts about the diagnosis remain, these often improve
if therapy progresses successfully.
Positive signs of FMD which demonstrate the potential for
normal movement
Demonstration that normal movement can occur (or that abnor-
mal movement can stop) alters expectations about movement
abnormalities, and can be a powerful way of convincing a scep-
tical patient (and their family) that their diagnosis of FMD is
correct and the problem is potentially reversible.20 Several clin-
ical signs to elicit normal movement and differentiate functional
symptoms from neurological disease have been described. These
are used as part of the diagnosis to positively identify FMDs,
rather than it being just a diagnosis of exclusion. Some of these
signs are listed in table 2.
Retraining movement with diverted attention
The challenge for the physiotherapist is to demonstrate normal
movement in the context of meaningful activity such as walking.
The key is to minimise self-focused attention by distracting or
preventing the patient from cognitively controlling movement
and to stimulate automatically generated movement. This can be
achieved by altering the focus of motor attention, such as think-
ing about a different part of the movement or trying fast, rhyth-
mical, unfamiliar or unpredictable movement.
Distraction can occur on a cognitive level, for example,
engaging attention away from the affected limb(s) with conver-
sation, music or mental tasks such as arithmetic. However,
task-orientated exercises (table 3) are preferred as they are often
more effective, translate directly into improved function and
encourage implicit motor control. Meaningful automatic move-
ment and muscle activity can be generated by weight bearing or
Box 1 General treatment principles for physiotherapy
for functional motor disorder (FMD)
▸ Build trust before challenging/pushing the patient.
▸ Project conﬁdence making it clear that the physiotherapist
knows about FMD.
▸ Create an expectation of improvement.
▸ Open and consistent communication between the
multidisciplinary team and patient.
▸ Involve family and carers in treatment.
▸ Limited ‘hands-on’ treatment. When handling the patient,
facilitate rather than support.
▸ Encourage early weight bearing. ‘On the bed strength’ will
not usually correlate with ability to stand in functional
weakness.
▸ Foster independence and self-management.
▸ Goal directed rehabilitation focusing on function and
automatic movement (eg, walking) rather than the
impairment (eg, weakness) and controlled (‘attention-full’)
movement (eg, strengthening exercises).
▸ Minimise reinforcement of maladaptive movement patterns
and postures.
▸ Avoid use of adaptive equipment and mobility aids (though
these are not always contra-indicated).
▸ Avoid use of splints and devices that immobilise joints.
▸ Recognise and challenge unhelpful thoughts and behaviours.
▸ Develop a self-management and relapse prevention plan.
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automatic postural responses such as when sitting on an unstable
surface (eg, a therapy ball). Table 3 includes further suggestions
of how to demonstrate normal movement in different situations
and other speciﬁc techniques for individual symptoms.
Other physiotherapy treatment strategies
Use of language
Using the right language may matter. Explanations that cor-
rectly remove blame, fault or implications of voluntariness are
useful. For example: “your brain is attending to your body in
an abnormal way”, or “tests have shown that your muscles are
capable of movement”, as opposed to “…you can move your
muscles.”
The words used when asking the patient to move may also be
important. Language may help trigger automatic movement, for
example, “allow your leg to come forward” may produce move-
ment in a better way than “step/move your leg forward.”
During physiotherapy sessions, you may pick up on cues or
prompts that are more useful for individual patients.
Exercise—non-speciﬁc and graded
Non-speciﬁc graded exercise should be considered as part of all
general rehabilitation programmes to address reduced exercise
tolerance and symptoms of chronic pain and fatigue. There is
some evidence for this in FMD.21 Success here is dependent on
getting the intensity right to prevent exacerbation of symptoms
and promote adherence/compliance with the programme.
Graded exercise has been shown in large randomised trials to
moderately improve outcomes in patients with chronic fatigue
syndrome22—a common accompaniment to FMD (see below)—
and is likely to be beneﬁcial to many patients.
Visualisation
Some patients may ﬁnd visualisation techniques helpful during
movement. This may work as a form of distraction whereby the
patient imagines a more ﬂuid motor task or pleasant scenario
while being engaged in tasks. Visualisation may be unhelpful if
it encourages self-focus during movement.
Mirrors and video
Mirrors and the use of video can be helpful in providing feed-
back to patients about their movements, posture or gait pattern
which are often signiﬁcantly different from how they imagine
them to be.23 Moving in front of a mirror may also help distract
attention from monitoring body sensations.
Hypersensitivity/allodynia
Interventions aimed at desensitisation may be appropriate where
hypersensitivity and allodynia are present. This can include
graded sensory stimulation, graded movement/exercise and
transcutaneous electrical nerve stimulation (TENS).
Rehabilitation diary or workbook
Completion of a rehabilitation diary or workbook with support
from the physiotherapist may be a useful technique to help the
patient reﬂect, remember and reinforce the information pro-
vided during physiotherapy. The patient can use the diary to
keep track of goals, outcome measures and achievements, treat-
ment strategies, activity plans, etc. A diary may help improve
compliance with treatment, and encourage self-management.
Pain and fatigue management
Persistent or chronic pain and fatigue are common in patients
with FMD and often have a role in precipitating and maintain-
ing symptoms. Preferably, the patient should have an under-
standing that these symptoms are all linked together as one
problem (with many symptoms) rather than multiple separate
illnesses. The core of evidence based treatments for pain and
fatigue involve, as suggested for FMD, (1) a change in illness
beliefs from perceiving symptoms as due to damage as poten-
tially reversible; (2) recognising that chronic pain is not corre-
lated with harm and (3) changing maladaptive behaviours, such
as breaking cycles of over-activity and under-activity with
graded exercise. It may be helpful to reformulate pain as
another example of the nervous system sending out incorrect
signals which, like FMD, can be helped by ‘re-training’ (ie,
establishing more normal motor-sensory feedback). A number
of good quality evidence based guides to pain management edu-
cation and helpful patient resources exist.24 25
Provision of equipment, adaptive aids, splints and plaster casts
We recommend avoiding adaptive aids where possible, especially
in acute presentations. Provision of equipment and adaptive aids
can lead to adaptive ways of functioning and behaviours that
prevent the return of normal movement and result in secondary
changes such as weakness and pain.
In some cases, use of equipment may be necessary for prag-
matic reasons (eg, to ensure safety after proven injuries), in which
case it should be considered as temporary and provided with a
plan to wean its use. We recommend ensuring that the patient
understands the potential harmful effects of equipment and a plan
should be in place to minimise this (eg, ensuring that the patient
Table 2 Clinical signs which can be shown to a patient with functional motor disorder to demonstrate the diagnosis and potential for
reversibility and examples of how to discuss it with patients
Hoover’s sign
Weakness of hip extension which returns to normal with contralateral hip flexion
against resistance
“I can see that when you try to push that leg down on the floor its weak, In fact the
harder you try the weaker it becomes. But when you are lifting up your other leg, can
you feel that the movement in your bad leg comes back to normal? Your affected leg
is working much better when you move your good leg. What this tells me is that your
brain is having difficulty sending messages to the leg but that problem improves
when you are distracted and trying to move your other leg. This also shows us that
the weakness must be reversible/cannot be due to damage”
Hip abductor sign
Weakness of hip abduction which returns to normal with contralateral hip abduction
against resistance
Similar to Hoover’s sign
Distraction or entrainment of a tremor
Abolishing tremor by asking the patient to copy rhythmical movements or generate
ballistic movements with the contralateral limb (ie, index to thumb tapping at
different speeds)
“When you are trying to copy the movement in your good hand can you see that the
tremor in your affected hand improves? That is typical of functional tremor”
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with a wheelchair has the opportunity to stand and mobilise as
much as is safe and possible). For patients with FMD who have
not responded to treatment, adaptive equipment may improve
independence and quality of life and should be considered.
We strongly advise against immobilising a patient in splints,
plaster casts or similar devices. In one study of ﬁxed (functional)
dystonia (n=103), 15% developed their problem or deteriorated
markedly during or after immobilisation in a plaster cast. In no
case did immobilisation in a plaster cast result in lasting
improvement.26
Electrotherapies—functional electrical stimulation,
electromyography feedback, transcranial magnetic stimulation and
TENS
The use of electricity has a long history in the treatment of
FMD and can be traced back to the 19th century.27 28 We
would not recommend any of these electrotherapies as isolated
treatments. Functional electrical stimulation (FES) may be a
useful adjunct to treatment, particularly in patients with a func-
tional gait disturbance.29 Ideally, FES should be used as a thera-
peutic modality and not as a permanent mobility aid. Electrical
Table 3 Examples of techniques for specific symptoms to normalise movement
Symptom Movement Strategy
Leg weakness Early weight bearing with progressively less upper limb support, eg, ‘finger-tip’ support, preventing the patient from taking weight through
walking aids/supporting surfaces
Standing in a safe environment with side to side weight shift
Crawling in 4 point then 2 point kneeling
Increase walking speed
Treadmill walking (with or without a body weight support harness and feedback from a mirror)
Ankle weakness Elicit ankle dorsiflexion activity by asking the patient to walk backwards, with anterior/posterior weight shift while standing or by asking the
patient to walk by sliding their feet, keeping the plantar surface of each foot in contact with the floor
Use of electrical muscle stimulation
Upper limb weakness Elicit upper limb muscle activity by asking the patient to bear weight through their hands (eg, 4 point kneeling or standing with hands resting on
a table) weight bearing with weight shift or crawling
Minimise habitual non-use by using the weak upper limb functionally to stabilise objects during tasks, for example, stabilise paper when writing,
a plate when eating
Practise tasks that are very familiar or important to the individual, that may not be associated with symptoms eg, use of mobile phone, computer
and tablet
Stimulate automatic upper limb postural response by sitting on an unstable surface such as a therapy ball, resting upper limbs on a supporting
surface
Gait disturbance Speed up walking (in some cases, this may worsen the walking pattern)
Slow down walking speed
Walk by sliding feet forward, keeping plantar surface of foot in contact with the ground (ie, like wearing skis). Progress towards normal walking in
graded steps
Build up a normal gait pattern from simple achievable components that progressively approximate normal walking. For example—side to side
weight shift, continue weight shift allowing feet to ‘automatically’ advance forward by small amounts; progressively increase this step length with
the focus on maintaining rhythmical weight shift rather than the action of stepping
Walk carrying small weights/dumbbells in each hand
Walking backwards or sideways
Walk to a set rhythm (eg, in time to music, counting: 1, 2, 1, 2…)
Exaggerated movement (eg, walking with high steps)
Walking up or down the stairs (this is often easier that walking on flat ground)
Upper limb tremor Make the movement ‘voluntary’ by actively doing the tremor, change the movement to a larger amplitude and slower frequency, then slow the
movement to stillness
Teach the patient how to relax their muscles by actively contracting their muscles for a few seconds, then relaxing
Changing habitual postures and movement relevant to symptom production
Perform a competing movement, for example, clapping to a rhythm or a large flowing movement of the symptomatic arm as if conducting an
orchestra
Focus on another body part, for example, tapping the other hand or a foot
Muscle relaxation exercises. For example, progressive muscle relaxation techniques, EMG biofeedback from upper trapezius muscle or using mirror
feedback
Lower limb tremor Side to side or anterior-posterior weight shift. When the tremor has reduced slow weight, shift to stillness
Competing movements such as toe-tapping.
Ensure even weight distribution when standing. This can be helped by using weighing scales and/or a mirror for feedback
Changing habitual postures relevant to symptom production. For example, reduce forefoot weight bearing
Fixed dystonia Change habitual sitting and standing postures to prevent prolonged periods in end of range joint positions and promote postures with good
alignment
Normalise movement patterns (eg, sit to stand, transfers, walking) with an external or altered focus of attention (ie, not the dystonic limb)
Discourage unhelpful protective avoidance behaviours and encourage normal sensory experiences (eg, wearing shoes and socks, weight bearing as
tolerated, not having the arm in a ‘protected’ posture
Prevent or address hypersensitivity and hypervigilance
Teach strategies to turn overactive muscles off in sitting and lying (eg, by allowing the supporting surface to take the weight of a limb. Cushions
or folded towels may be needed to bring the supporting surface up to the limb where contractures are present)
The patient may need to be taught to be aware of maladaptive postures and overactive muscles in order to use strategies
Consider examination under sedation, especially if completely fixed or concerned about contractures
Consider a trial of electrical muscle stimulation or functional electrical stimulation to normalise limb posture and movement
Functional Jerks/
Myoclonus
Movement retraining may be less useful for intermittent or sudden jerky movements. Instead, look for self-focused attention or premonitory
symptoms prior to a jerk that can be addressed with distraction or redirected attention
When present, address pain, muscle over-activity or altered patterns of movement that may precede a jerk
EMG, electromyography.
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muscle stimulation (not necessarily FES) can be used to demon-
strate normal movement and help change illness beliefs. It may
also work at the level of motor relearning.
Electromyography (EMG) biofeedback can be used to address
illness beliefs and may be useful to retrain movement in functional
weakness30 or muscle relaxation for tremor and ﬁxed postures.
Recent studies of transcranial magnetic stimulation (TMS)
also offer some promise.31 None of the published studies were
controlled and none involved exposure to protocols of TMS
that could be considered neuromodulatory. It is most likely that
placebo and suggestion play a large role in patients where this is
successful, although TMS may have a speciﬁc role, like hypnosis
or therapeutic sedation,32 33 in being able to demonstrate move-
ment in limbs that cannot be seen to move any other way.34
TMS, like FES, may therefore be a useful additional tool for
some patients, and one that specialised physiotherapists could
incorporate into their practice.
TENS, which produces a tingling sensation without pain or a
muscle twitch, has been described as a treatment for patients
with FMD.35 For patients with functional anaesthesia or marked
sensory loss, we have used a TENS machine with the stimulus
setting increased to a high level to improve sensory awareness.
Falls and self-harming behaviour
Falls in patients with FMD are often considered to have a low
risk of injury, in particular the common pattern of ‘controlled
descents’. Where this is the case, staff should be made aware of
this possibility and it may be appropriate for the patient to take
greater (apparent) risk. The situation is more complex where
there is a history of self-harm which may sometimes manifest as
a fall. The risk of injury during therapy sessions is likely to be
higher. In this case, clinical decisions should be made with
support from a multidisciplinary team (MDT). The physiother-
apist can help manage this situation by being upfront about falls
injury risk, document discussions and clinical decisions in the
medical notes and encourage the patient to be involved in
decision-making.
TECHNIQUES WE DO NOT RECOMMEND
There are a number of rehabilitation approaches described in
the literature that we advise against using as ﬁrst-line treatment.
These are:
1. Deception of the patient through any form. For example, telling
the patient that lack of recovery means the symptoms are all in
the mind,36 including the use of deceptive placebo treatments.
2. Conﬁning the patient to a wheelchair outside of therapy ses-
sions while their gait pattern remained affected by functional
symptoms.37
3. Managing functional symptoms with surgery. Surgical proce-
dures are a commonly reported precipitant of FMD.10 26
Some patients with ﬁxed functional dystonia seek amputa-
tions which usually result in a worsening of symptoms.38
There may be a role for tendon lengthening surgeries in
cases with ﬁxed contractures conﬁrmed by evaluation under
anaesthesia; however, this comes with a risk of exacerbating
functional symptoms and chronic pain.
TREATMENT PARAMETERS
The optimum treatment setting, duration and intensity are
unknown and are likely to vary with symptom severity, chronicity
and possibly presentation/phenotype. Inpatient settings allow for
the reduction of social and environmental factors that may be
working to trigger or maintain symptoms and for higher intensity
of treatment. Domiciliary treatment can target real world
problems that the patient will face on discharge, which may
result in symptom relapse. Outpatient settings have the advantage
of service provision over a longer period of time. A ‘stepped care’
approach to treatment is the ideal situation, where treatment
complexity can be escalated according to patient need.39
OUTCOME MEASURES
This is an unresolved issue in studies of FMD. Changes in disabil-
ity (eg, using the Functional Independence Measure),40–43 quality
of life (eg, the SF-36), clinical global impression (5 point scale)2 44
and cost beneﬁt have been used. Objective research measures for
FMD, such as the Psychogenic Movement Disorders Rating
Scale,45 have questionable value in clinical practice and also for
research because FMD symptoms are so variable.
DISCHARGE AND FOLLOW-UP/CONCLUDING TREATMENT
A set discharge process agreed at the start of treatment
(Treatment Contract/Agreement) is beneﬁcial as it helps both
parties plan for the conclusion of treatment and limit potential
associated problems. A self-management plan should be in place
that may include strategies and exercises that have been helpful,
future goals with realistic time frames and strategies to prevent a
return to unhelpful behaviours (eg, pacing, graded activity and
exercise plans to prevent boom-bust activity cycles). Setbacks
and symptom relapses following treatment are common and it is
important for the patient to be prepared to manage this.
A follow-up appointment several months after discharge can be
helpful to review and reset goals and to ‘troubleshoot’ issues
that may have arisen.
A discharge summary letter to the patient, general practitioner
and relevant clinicians can have therapeutic value if it is used as
an opportunity to reinforce information given to the patient
and to educate others about the diagnosis and treatment.
FMD AND PSYCHIATRIC COMORBIDITY
Patients with psychiatric comorbidity are generally more highly
represented in a group of patients with FMD compared to the
general population. For some patients, psychiatric comorbidity
may be present, relevant to the onset of FMD and require spe-
cialist psychiatric treatment. This may need to be before (eg,
where an individual is at risk of self-harm or reluctant to engage
in physical rehabilitation), during or after physiotherapy. Our
experience is that psychotherapy (in particular, treatment for
anxiety and depression) is often more successful after some
improvement has occurred during physiotherapy.
LIMITATIONS
This document aims to address the problem of a lack of infor-
mation and evidence for physiotherapists treating patients with
FMD. We recognise that there are a number of limitations to
our recommendations. Most signiﬁcant is that they are based on
limited evidence. Our aim is only to provide advice for phy-
siotherapists. We recognise that physiotherapy is only one part
of the MDT, and other disciplines such as occupational therapy
and psychological therapies may have an equal or greater role in
particular patients. Patients with FMD are a heterogeneous
group and each patient will have unique factors contributing to
their symptoms.
CONCLUSIONS/SUMMARY
FMDs are complex and the aetiology is multifactorial. Patients
with this diagnosis are therefore heterogeneous. Treatment needs
to reﬂect this. Physiotherapy aimed at restoring movement and
function has face validity, is becoming evidence based and is
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acceptable to patients. Physiotherapy resources are currently
employed for patients with FMD, but the supporting structures do
not exist and there is a lack of information for physiotherapists to
help plan their treatment. The biopsychosocial model and recom-
mendations that we present are aimed at helping physiotherapists
to plan individualised treatments that target the problems that con-
tribute to a patient’s symptoms. A stepped care approach is
important to escalate treatment when necessary.
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